New Delhi:
The Uttarakhand government told the Supreme Court in an affidavit that it has granted permission to file a complaint against Baba Ramdev's Divya Pharmacy and Patanjali Ayurved Ltd. for repeated violations of the Drug Advertising Act and the suspended manufacturing licenses for 14 of their products.
In the affidavit, the Uttarakhand government stated that its State Licensing Authority has issued a public notice indicating that publication of advertisements in violation of the law would attract strict disciplinary and legal action, including fines, imprisonment or both.
The affidavit filed by the State Licensing Authority, Ayurvedic and Unani Services, states that on April 12, it granted permission to the Haridwar drug inspector to file a complaint against Divya Pharmacy and Patanjali Ayurved Ltd. for repeated violations of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.
“The SLA issued an order dated April 15, 2024 to Divya Pharmacy and Respondent No. 5-Patanjali Ayurved Ltd. stating that the manufacturing licenses for 14 of their products namely 'Swasari Gold', 'Swasari Vati, Bronchom ', 'Swasari Pravahi', 'Swasari Avaleh', 'MuktaVati Extra Power', 'Lipidom', 'Bp Grit', 'Madhugrit', 'MadhunashiniVati Extra Power', 'Livamrit Advance', 'Livogrit', 'Eyegrit Gold' and 'Patanjali Drishti Eye Drop', have been suspended with immediate effect under Rule 159(1) of the Drugs and Cosmetics Rules, 1945,” the report said.
“The District Ayurvedic and Unani Officer, Haridwar has filed a criminal complaint before the Chief Judicial Magistrate, Haridwar against Swami Ramdev, Acharya Balkrishna, Divya Pharmacy and Patanjali Ayurved Limited under Sections 3, 4 and 7 of the Drugs and Magic Remedies ( offensive advertisements) Act, 1954,” the affidavit added.
The SLA said it will continue to take all necessary and further action against Divya Pharmacy and Patanjali Ayurved Ltd, as per the procedure prescribed under the law and the directions of the Supreme Court.
In an order dated April 10, the top court had ordered the then joint director of the State Licensing Authority and all officers holding the post of District Ayurvedic and Unani Officer, Haridwar from 2018 to date to file their respective affidavits stating the passivity was explained. their share.
The Indian Medical Association has taken action against Patanjali for violating the Drugs and Magic Remedies (Objectionable Advertising) Act, which bans advertising of certain products for the treatment of specific diseases and conditions, including diabetes, heart disease, high or low blood pressure and obesity.
The Ayurvedic company had earlier pledged in the Supreme Court that it would not make casual statements claiming the medicinal efficacy of its products, or advertise or brand in violation of the law, and that it would not make any statements against any medical system would also release to the authorities. media in any form.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)